Back to Agenda
Session 5 Users’ Experiences and Perspectives Regarding Biosimilars and Considerations on National Policy Developments
Session Chair(s)
Sabine Atzor, MPharm, RPh
Head of EU Regulatory Policies
F. Hoffmann-La Roche Ltd, Switzerland
Suzette Kox, MPharm
Senior Director International-Biosimilars Medicines Group
Medicines for Europe, Belgium
The session will continue by giving floor to health care professionals and patients and their points of view on the policy developments.
Speaker(s)
![Carl-Erik Flodmark](/_Images/member/Generic_Image_Missing-Profile.jpg)
Carl-Erik Flodmark
Childhood Obesity Unit Region Skane, Sweden
Chief medical officer at Childhood
![Thijs Giezen, PharmD, PhD, MSc](/_Images/member/Generic_Image_Missing-Profile.jpg)
Biosimilars in Clinical Practice: the Perspective of the Hospital Pharmacist
Thijs Giezen, PharmD, PhD, MSc
Medicines Evaluation Board, Netherlands
Patients' perspectives
Marco Greco, PhD
European Patients' Forum, Belgium
President
![Margaret Dolan](/_Images/member/Generic_Image_Missing-Profile.jpg)
Payer's perspective
Margaret Dolan
NHS Commercial Solutions, United Kingdom
Regional Pharmacy Procurement Specialist
Have an account?